Entropy Technologies LP Buys Shares of 70,105 Agilent Technologies, Inc. $A

Entropy Technologies LP bought a new stake in Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, Holdings Channel.com reports. The fund bought 70,105 shares of the medical research company’s stock, valued at approximately $9,539,000.

Several other large investors have also recently bought and sold shares of the company. Avidity Partners Management LP bought a new stake in Agilent Technologies in the fourth quarter valued at approximately $5,647,000. Barclays PLC increased its stake in Agilent Technologies by 9.5% in the fourth quarter. Barclays PLC now owns 780,761 shares of the medical research company’s stock valued at $106,238,000 after purchasing an additional 68,000 shares in the last quarter. Aigen Investment Management LP bought a new stake in Agilent Technologies in the fourth quarter valued at approximately $659,000. Arrowstreet Capital Limited Partnership increased its stake in Agilent Technologies by 116.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 919,383 shares of the medical research company’s stock valued at $125,100,000 after purchasing an additional 494,006 shares in the last quarter. Finally, Aptus Capital Advisors LLC increased its stake in Agilent Technologies by 6.0% in the fourth quarter. Aptus Capital Advisors LLC now owns 3,510 shares of the medical research company’s stock valued at $478,000 after purchasing an additional 198 shares in the last quarter.

Agilent Technologies Stock Up 0.2%

Shares of A stock opened at $129.76 on Friday. The firm has a fifty day moving average of $120.24 and a 200-day moving average of $127.86. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a market capitalization of $36.65 billion, a price-to-earnings ratio of 26.06, a P/E/G ratio of 2.31 and a beta of 1.26.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.84 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the prior year, the firm earned $1.31 earnings per share. The firm’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. HSBC lowered their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. TD Cowen upped their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Finally, Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $160.93.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.